Anthem Blue Cross and Blue Shield | CommercialNovember 1, 2024
Notice of material change/amendment to contract
Precertification List Change Notification — November 1, 2024
The following services will be added to precertification for the effective dates listed below.
Eligibility and benefits can be verified by accessing Availity at Availity.com or calling Anthem’s Utilization Management department using the number on the back of the member’s identification card. Service preapproval is based on member’s benefit plan/eligibility at the time the service is reviewed/approved.
Precertification can help avoid unnecessary charges or penalties by helping to ensure that the member's care is medically necessary and administered at an appropriate network facility and by a network provider.
Add to precertification | |||
Criteria | Criteria description | Code | Effective date |
MED.00140 | Gene Therapy for Beta Thalassemia | J3393 | 2/1/2025 |
MED.00146 | Gene Therapy for Sickle Cell Disease | J3394 | 2/1/2025 |
Anthem Blue Cross and Blue Shield is the trade name of Anthem Health Plans of Maine, Inc. Independent licensee of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.
MULTI-BCBS-CM-068529-24
PUBLICATIONS: November 2024 Provider Newsletter
To view this article online:
Or scan this QR code with your phone